Latest Europe News

The Geological Survey of Sweden has proposed designating Aura Energy’s Häggån polymetallic deposit as a national interest, potentially securing legal protections that support Europe’s clean energy ambitions through critical minerals like uranium and vanadium.

Vulcan Energy has officially started full-scale construction of its Lionheart lithium chemicals facility in Frankfurt, targeting a 2028 commercial production start with a capacity to supply 500,000 EV batteries annually.

Phoslock Environmental Technologies reported a stable sales volume and improved cash flow compared to last year, while ramping up production after reopening its Chinese factory. The company is advancing R&D on a new lanthanum product and faces ongoing legal challenges with mediation set for June.

Little Green Pharma has pushed back the Federal Court hearing for its Cannatrek acquisition to late May, setting a new timetable that includes a shareholder vote on May 22 and implementation targeted for June 1.

Aldoro Resources has achieved an exceptional ~99% strontium extraction from its Kameelburg Project ore using simple ambient-temperature acid leaching, positioning the asset as a rare, low-complexity source amid soaring global strontium prices and supply disruptions.

XRF Scientific is set to broaden its industrial reach by acquiring Bruker’s Combustion Gas Analysis business for USD 4 million, adding a profitable product line and new market sectors.

Zinc Mines Ireland (ASX: ZMI) has acquired Dutch metals tech firm Meclex, integrating its proprietary low-temperature hydrometallurgical processes into ZMI’s Kildare zinc project. The move aims to unlock critical mineral value and reduce environmental impact in European zinc and battery recycling markets.

Treasury Wine Estates is reshaping its global operations into four regional divisions to sharpen market execution and efficiency. The company reports improved third-quarter sales in China and the US, bolstered by luxury brand Penfolds, while securing $300 million in new debt to strengthen liquidity beyond $1 billion by fiscal 2026 end.

The L1 Global Long Short Fund (ASX:GLS) faced a challenging March quarter amid the Iran War-driven oil supply shock but maintains strong performance since inception through active portfolio adjustments and thematic focus on copper, gold, and infrastructure.

Starpharma has secured FDA alignment on the clinical development plan for its DEP® HER2 radiotherapy candidate, paving the way for a first-in-human phase 1 study in advanced HER2-positive cancers scheduled for H2 2026.

Little Green Pharma has postponed the shareholder vote on issuing new shares tied to its Cannatrek acquisition, pushing the decision back a month to allow time to meet outstanding conditions. Other resolutions will proceed as planned on April 22.

ION Video has trimmed its monthly cash burn to $148,000, beating management’s forecast, and expects to maintain sufficient funding until at least mid-2027. Meanwhile, early-stage discussions with tech giants Meta and Alphabet remain active but non-binding.